The emerging role of selenium metabolic pathways in cancer: New therapeutic targets for cancer-Reference-Cited by-同舟云学术

The emerging role of selenium metabolic pathways in cancer: New therapeutic targets for cancer

Published:2021-12-21 Issue: Volume: Page:
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J of Cellular Biochemistry

Author:

Kalimuthu Kalishwaralal¹²,Keerthana Chenicheri K.²,Mohan Manikandan³⁴,Arivalagan Jaison⁵,Christyraj Johnson Retnaraj Samuel Selvan⁶,Firer Michael A.⁷⁸⁹,Choudry Mohammad Haroon Asif¹,Anto Ruby John²,Lee Yong J.¹^ORCID

Affiliation:

1. Department of Surgery, School of Medicine University of Pittsburgh Pittsburgh Pennsylvania USA

2. Division of Cancer Research Rajiv Gandhi Centre for Biotechnology Thiruvananthapuram Kerala India

3. College of Pharmacy University of Georgia Athens Georgia USA

4. VAXIGEN International Research Center Private Limited Coimbatore India

5. Department of Chemistry, Molecular Biosciences and Proteomics Center of Excellence Northwestern University Evanston Illinois USA

6. Regeneration and Stem Cell Biology Lab, Centre for Molecular and Nanomedical Sciences, International Research Centre Sathyabama Institute of Science and Technology Chennai Tamilnadu India

7. Department of Chemical Engineering Ariel University Ariel Israel

8. Adelson School of Medicine Ariel University Ariel Israel

9. Ariel Center for Applied Cancer Research Ariel University Ariel Israel

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.30196

Reference93 articles.

1. Mitochondrial TXNRD3 confers drug resistance via redox-mediated mechanism and is a potential therapeutic target in vivo

2. Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib